Min Li , Liyu Zhu , Guangquan Zhou , Jianan He , Yanni Jiang , Yang Chen
{"title":"Predicting the pathological status of mammographic microcalcifications through a radiomics approach","authors":"Min Li , Liyu Zhu , Guangquan Zhou , Jianan He , Yanni Jiang , Yang Chen","doi":"10.1016/j.imed.2021.05.003","DOIUrl":null,"url":null,"abstract":"<div><p><strong>Objective</strong> The study aimed to develop a machine learning (ML)-coupled interpretable radiomics signature to predict the pathological status of non-palpable suspicious breast microcalcifications (MCs).</p><p><strong>Methods</strong> We enrolled 463 digital mammographical view images from 260 consecutive patients detected with non-palpable MCs and BI-RADS scored at 4 (training cohort, <em>n</em> = 428; independent testing cohort, <em>n</em> = 35) in the First Affiliated Hospital of Nanjing Medical University between September 2010 and January 2019. Subsequently, 837 textures and 9 shape features were subsequently extracted from each view and finally selected by an XGBoost-embedded recursive feature elimination technique (RFE), followed by four machine learning-based classifiers to build the radiomics signature.</p><p><strong>Results</strong> Ten radiomic features constituted a malignancy-related signature for breast MCs as logistic regression (LR) and support vector machine (SVM) yielded better positive predictive value (PPV)/sensitivity (SE), 0.904 (95% CI, 0.865–0.949)/0.946 (95% CI, 0.929–0.977) and 0.891 (95% CI, 0.822–0.939)/0.939 (95% CI, 0.907–0.973) respectively, outperforming their negative predictive value (NPV)/specificity (SP) from 10-fold cross-validation (10FCV) of the training cohort. The optimal prognostic model was obtained by SVM with an area under the curve (AUC) of 0.906 (95% CI, 0.834–0.969) and accuracy (ACC) 0.787 (95% CI, 0.680–0.855) from 10FCV against AUC 0.810 (95% CI, 0.760–0.960) and ACC 0.800 from the testing cohort.</p><p><strong>Conclusion</strong> The proposed radiomics signature dependens on a set of ML-based advanced computational algorithms and is expected to identify pathologically cancerous cases from mammographically undecipherable MCs and thus offer prospective clinical diagnostic guidance.</p></div>","PeriodicalId":73400,"journal":{"name":"Intelligent medicine","volume":"1 3","pages":"Pages 95-103"},"PeriodicalIF":4.4000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.imed.2021.05.003","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligent medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667102621000127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS","Score":null,"Total":0}
引用次数: 3
Abstract
Objective The study aimed to develop a machine learning (ML)-coupled interpretable radiomics signature to predict the pathological status of non-palpable suspicious breast microcalcifications (MCs).
Methods We enrolled 463 digital mammographical view images from 260 consecutive patients detected with non-palpable MCs and BI-RADS scored at 4 (training cohort, n = 428; independent testing cohort, n = 35) in the First Affiliated Hospital of Nanjing Medical University between September 2010 and January 2019. Subsequently, 837 textures and 9 shape features were subsequently extracted from each view and finally selected by an XGBoost-embedded recursive feature elimination technique (RFE), followed by four machine learning-based classifiers to build the radiomics signature.
Results Ten radiomic features constituted a malignancy-related signature for breast MCs as logistic regression (LR) and support vector machine (SVM) yielded better positive predictive value (PPV)/sensitivity (SE), 0.904 (95% CI, 0.865–0.949)/0.946 (95% CI, 0.929–0.977) and 0.891 (95% CI, 0.822–0.939)/0.939 (95% CI, 0.907–0.973) respectively, outperforming their negative predictive value (NPV)/specificity (SP) from 10-fold cross-validation (10FCV) of the training cohort. The optimal prognostic model was obtained by SVM with an area under the curve (AUC) of 0.906 (95% CI, 0.834–0.969) and accuracy (ACC) 0.787 (95% CI, 0.680–0.855) from 10FCV against AUC 0.810 (95% CI, 0.760–0.960) and ACC 0.800 from the testing cohort.
Conclusion The proposed radiomics signature dependens on a set of ML-based advanced computational algorithms and is expected to identify pathologically cancerous cases from mammographically undecipherable MCs and thus offer prospective clinical diagnostic guidance.